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http:WHAT THIS PAPER ADDS
The purpose of this study is to describe the concept and experience of using temporary aneurysm sac perfusion
with second stage side branch completion, as an adjunct to reduce the risk of severe spinal cord ischemia after
branched endovascular repair of thoracoabdominal aortic aneurysms.Objective: To report experience with the concept of temporary aneurysm sac perfusion (TASP) and second stage
side branch completion to prevent severe spinal cord ischemia (SCI) after branched endovascular aortic repair
(bEVAR) for thoracoabdominal aortic aneurysm (TAAA).
Methods: Patients were treated for TAAA with bEVAR between January 2009 and September 2012. TASP was
performed by non-completion of side branches to one of the reno-visceral arteries, distal aortic or iliac
extensions with secondary side branch completion. Primary endpoints of the study were overall technical
success, side branch patency, perioperative mortality, and the rate of severe SCI.
Results: Eighty-three patients were treated for TAAA with branched aortic stent grafts with (n ¼ 40) or without
(n ¼ 43) TASP. Overall technical success, including aneurysm exclusion, absence of persistent type I or III
endoleak, TASP side branch patency, and secondary side branch completion was 35/40 (88%). Secondary TASP
side branch completion was performed after a median of 48 days (range 1e370 days). The rate of early re-
interventions for reno-visceral side branch complications was 8/283 (3%) and 6/83 (7%) for perioperative
mortality, with three patients in both groups. Severe SCI or paraplegia was observed in 11/83 (13%) of the
patients and reduced in the TASP group (2/40) compared with the non-TASP group (9/43; p ¼ .03), especially in
Crawford IeIII aneurysms (1/29 vs. 7/24; p ¼ .01). However, one TASP patient died 4 months after bEVAR during
the TASP interval from suspected aorto-bronchial ﬁstula.
Conclusion: The concept of TASP after bEVAR for TAAA is feasible and seems to reduce the risk of SCI. Early side
TASP branch completion within 4 weeks is recommended to reduce the risk of rupture, although, according to
the individual clinical presentation, a longer TASP interval might improve neurological rehabilitation from SCI.
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Endovascular aortic repair using branched stent grafts
(bEVAR) is an additional minimally invasive therapeutic
option for patients with thoracoabdominal aneurysms
(TAAAs).1e4 However, perioperative spinal cord ischemia
(SCI) with paraplegia or paraparesis is still a severe
complication after bEVAR, with an incidence of 0e20%.5,6To access continuing medical education questions on this paper,
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Open access under CC BY-NC-ND license.The risk of SCI increases with the extend of the thor-
acoabdominal aneurysm, the length of the stent grafts used
covering intercostal and lumbar arteries, pre-existing aortic
reconstruction of the ascending or descending thoracic
aorta, and occlusions of supra-aortic or hypogastric ar-
teries.7e9 During extended thoracoabdominal aortic repair
for TAAA the reduction of spinal cord perfusion seems to be
mediated by occlusion of the intercostal and lumbar arteries
at the proximal and distal landing zones immediately after
stent graft implantation and as a secondary effect by pro-
gressive thrombosis of the aneurysm sac, causing early or
delayed SCI, even after 24e72 h.10,11
Spinal cord perfusion is mediated by posterior intercostal
and lumbar arteries predominantly at the level of Th8eL2
with further blood supply provided by branches of the left
subclavian and vertebral artery, and by both hypogastric
Figure 1. Number of patients treated annually during the study
period without (non-TASP) or with temporary aneurysm sac
perfusion (TASP).
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spinal cord perfusion is mediated by a collateral spinal
network represented by paraspinous arterial collaterals,
segmental spinal arteries, and dorsal branches of posterior
intercostal and lumbar arteries.14 Furthermore, based on
experimental and clinical studies staged interventions with
two-step coverage or ligation of thoracic intercostals and
lumbar arteries had lower rates of SCI, probably caused by
expansion of a pre-existing collateral network or newly
formed vessels leading to maintenance of spinal cord
perfusion.15,16
The concept of temporary aneurysm sac perfusion (TASP)
is based on the hypothesis that non-completion of at least
one stent graft side branch is expected to prevent complete
aneurysm sac thrombosis and maintain spinal cord perfu-
sion through patent intercostal and/or lumbar arteries with
the intention of reducing the risk of SCI after bEVAR. The
idea of temporary aneurysm sac perfusion has so far been
reported in two case reports and a small patient series with
either induction of an endoleak after the appearance of SCI
in one patient or by using speciﬁcally constructed stent
grafts with upward and downward directed additional side
branches facilitating aneurysm sac perfusion.17e19
In this report, early experience using standard or custom-
made branched endografts for the treatment of TAAA with
TASP and staged completion of organ perfusing side
branches to reduce the risk of SCI is reported.METHODS
Study design
In this single centre study feasibility and early perioperative
outcome using the concept of TASP was evaluated in pa-
tients with TAAA receiving bEVAR between January 2009
and September 2012 compared with patients having bEVAR
with immediate side branch completion (non-TASP). The ﬁrst
patient was treated with bEVAR and TASP in January 2008
with non-completion of the right stenotic renal artery and
the clinical observation that this patient almost completely
recovered from paraplegia within few weeks. The TASP
concept was used from January 2009 as an additional
adjunct to cerebrospinal ﬂuid (CSF) drainage and mainte-
nance of stable hemodynamics, and recommended for every
patient receiving bEVAR for TAAA, except for those having
contraindications for side branch non-completion, as
described later in the section “TASP” or those refusing a
secondary intervention for side branch completion.Patients
Patients with a TAAA >5.5 cm, rapid aneurysm progression
of >5 mm within 6 months, or symptomatic patients were
included. Patients with ruptured aneurysms were excluded.
Every patient was discussed by the institutional vascular
review board and informed consent was obtained from
each patient after detailed explanation of the risks and
possible beneﬁts. The annual number of patients treated
with TASP or without TASP (non-TASP) is shown in Fig. 1.Patients with Crawford type I aneurysms were treated as
Crawford type II aneurysms because the distal stent graft
landing zone was usually in the infrarenal aortic segment.Endovascular technique
Standard design or custom-made branched aortic endog-
rafts were individually planned in cooperation with Cook
Planning Center, Perth, Australia and London, UK, and
constructed by Cook Endovascular Laboratory (Brisbane,
Australia). Endovascular aortic interventions were per-
formed using a mobile C-arm (OEC 9900 Elite; GE, Paris,
France) or in a Hybrid operating room (Philips, Allura Xper
FD 20; Philips Healthcare, DA Best, the Netherlands). For
side branch organ perfusion Advanta V12 (Atrium Medical,
Hudson, NH, USA) or Fluency plus (C.R. Bard, Angiomed,
Karlsruhe, Germany) stent grafts were used. Visceral stent
grafts were aligned using uncovered stents (Wallstent,
Boston Scientiﬁc, Natick, MA, USA; or Zilver Flex, Cook
Medical, Bloomington, IN, USA). Ten patients had endog-
rafts with both fenestrations and branches: three patients
with three fenestrations and eight branches in the non-
TASP group, and seven patients with 16 fenestrations and
12 branches in the TASP group. For all patients CSF drainage
was intended and strict perioperative prevention of hypo-
tension was part of the perioperative management.TASP
For TASP preferentially the celiac trunk was left non-
completed after uncomplicated superior mesenteric artery
(SMA) and renal artery stent graft implantation. Other op-
tions for side branch non-completion were side branches to
an accessory renal artery; a pre-existing high-grade stenotic
renal artery with a hypoplastic kidney; a patent inferior
mesenteric artery; a solitary hepatic or splenic artery, with
an arterial diameter >4 mm for all arteries mentioned
before; or non-completion of an aortoiliac stent graft
extension in patients treated with a bifurcated stent graft.
Contraindications for non-completion of the celiac trunk
were complications during side branch stent grafting of the
SMA with local dissection of the main SMA branch or loss of
Table 2. Patient (n ¼ 83) characteristics, risk factors and
aneurysm-related parameters.
Characteristic Non-TASP TASP p
Mean age (years) 71.35  1.5 72.8  1.2 .45
Male 29 26 d
Female 14 14 0.814
Aneurysm type
Crawford I 5 5 d
Crawford II 4 6 d
Crawford III 15 18 d
Crawford IV 19 11 .29
Aneurysm diameter
<5.0 cm 1 1 d
5.1e6.0 cm 15 14 d
6.1e7.0 cm 16 11 d
7.1e8.0 cm 5 7 d
260 P.M. Kasprzak et al.distal arterial segments of the SMA. Post-nephrectomy
status or reduced renal function with a glomerular ﬁltra-
tion rate <30 mL/min excluded non-completion of the
remaining, or one of the renal arteries and pre-existing
high-grade arteriosclerotic stenosis of the iliofemoral ar-
teries was an argument against non-completion of one of
the aortoiliac stent graft extensions. Secondary TASP side
branch completion was recommended within 4 weeks of
the initial bEVAR, and all patients with symptomatic TAAA
had primary side branch completion.
Endpoints of the study
Primary endpoints included overall technical success, peri-
operative mortality, and freedom from severe SCI after 30
days or at discharge. Secondary endpoints were the rate of
early reinterventions, reno-visceral organ dysfunction and
any neurological event other than severe SCI. Overall
technical success according to the TASP concept was
deﬁned as bEVAR, patent TASP side branch or aortoiliac
extension, absence of persistent and non-intended type I or
type III endoleak, and secondary TASP side branch
completion. Type II or type IV endoleaks were not consid-
ered for evaluation of technical success.
Neurological evaluation
Neurological evaluation of symptoms related to SCI were
classiﬁed according to the modiﬁed Tarlov paraplegia
scoring scale (0e5), focusing on the description of deﬁcits
of motor neuron function.20,21 The description of the ele-
ments of the modiﬁed Tarlov scoring scale is shown in
Table 1. Modiﬁed Tarlov scales (0e2) were considered for
classiﬁcation of severe SCI in the present study.
Analysis of patent intercostal and lumbar arteries
Patent intercostal and lumbar arteries visible on computed
tomographic angiogram (CTA) were counted in each patient
from the level of the left subclavian artery to the aortic
bifurcation. The assessment was performed twice in everyTable 1. Modiﬁed Tarlov scale for classiﬁcation of spinal cord
ischemia.
Scale
0 No leg movements with bilateral paraplegia, loss
of bowel and bladder control
1 Minimal leg movement without gravity,
incomplete unilateral paraplegia, patient cannot
sit or stand loss of bowel and bladder control
2 Some coordinated leg movements against gravity,
patient can sit and stand with assistance loss of
bowel and bladder control
3 Ability to stand and walk with help; hip instability,
loss of bowel and bladder control
4 Walking with some leg and hip instability, mostly
without assistance, and with bowel and bladder
control
5 Almost normal muscle motor function, walking
with minor hip instability, normal sphincter
functionpatient by two different investigators (G.C. and R.K.) and
calculated for the non-TASP and TASP group before the
endovascular treatment, and before and after secondary
side branch completion in the TASP group.Postoperative evaluation
Postoperative evaluation included B-mode and cw-duplex
sonography, abdominal radiography in four planes, CTA,
and contrast-enhanced ultrasonography usually performed
within 3e5 days of the endovascular procedure, before and
after secondary side branch completion, after 6 months,
and then at yearly intervals or in any case of suspected
organ malperfusion or dysfunction. Duplex and contrast-
enhanced ultrasonography were used postoperatively to
differentiate between intended TASP side branch perfusion
and non-intended type I or III endoleaks, especially in pa-
tients with acute or chronic renal failure.22Data collection and statistical analysis
Data were collected prospectively in an institutional data-
base and analyzed retrospectively. Data were analyzed using
SPSS version 20.0 (IBM, Armonk, NY, USA). Descriptive data>8.0 cm 6 7 .87
Previous aortic repair
None 30 26 d
Endovascular aortic repair 4 3 d
Open aortic surgery 10 10 .83
Endograft side branches
3 8 3 d
4 31 26 d
5 2 2 d
6 0 1 .45
Branches and fenestrations 3 7 .10
Cardiovascular risk factors
Hypertension 39 38 .45
Coronary heart disease 22 21 .90
Renal insufﬁciency/dialysis 11/3 15/1 .35/.34
Chronic obstructive
pulmonary disease
13 11 .83
Stroke 5 10 .11
Smoking 28 24 .80
Note. TASP ¼ temporary aneurysm sac perfusion.
Table 3. Branches for temporary aneurysm sac perfusion (TASP).
Non-completed TASP branches n %
Celiac trunk 20 50
Renal artery 9 23
Hepatic or inferior mesenteric artery 2 4
Distal aortoiliac extension 9 23
Note. Number of patients was 40.
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values. Possible correlations between variables were
calculated using a chi-square test with Pearson’s or Fisher’s
exact test to indicate statistical signiﬁcance. A p-value <.05
was considered to be statistically signiﬁcant.
RESULTS
Branched EVAR for TAAA
Endovascular exclusion of thoracoabdominal aneurysms
was performed in 83 patients using branched endografts.
TASP was performed in 40 patients versus 43 patients
receiving bEVAR without TASP (non-TASP). The character-
istics of patients and thoracoabdominal aneurysms treated
are shown in Table 2. Branched endografts implanted for
endovascular TAAA repair had a mean of 3.6 side branches
per patient (range 1e6) with an overall perioperative
patency rate of 95%. Ten patients had endografts with
both fenestrations and branches. CSF pressure was
measured in 79/83 (95%) patients and kept <10 mmHg
during the intervention and the ﬁrst 3e5 postoperative
days.TASP side branches
Temporary aneurysm sac perfusion was performed by non-
completion of the side branches to the celiac trunk
(n ¼ 20; 50%), the renal arteries (n ¼ 9; 23%), inferior
mesenteric or separate hepatic artery (n ¼ 2; 5%) or distal
aortic or iliac extensions (n ¼ 9, 23%; Table 3) with a
patency of the TASP side branches or aortoiliac extensions
of 39/40 (98%). Figs. 2e4 show examples of the TASP
procedure with open branches to one of the reno-visceral
arteries, perfusion of intercostal or lumbar arteries, andFigure 2. Computed tomographic angiography showing a Crawford type
endograft with non-completed side branch to the left kidney. (A) Tem
aneurysm sac and perfusion of the dorsal branch of the posterior interc
TASP side branch was performed after 49 days with maintenance of premaining spinal cord perfusion after secondary side
branch completion, as shown by CTA. TASP side branch
patency was 39/40 (98%), with one celiac side branch
occlusion due to compression of the side branch by the
anterior position of the stent graft main body within a
kinked aortic segment.TASP interval and secondary side branch completion
The time interval between initial implantation of branched
endograft with TASP and secondary side branch completion
or iliac extension was a median of 48.0 days (mean
60.7  12.9 days) with a wide range (1e370). Reasons for
late side branch completion were a general fear of any
reintervention in asymptomatic patients (n ¼ 6); a severe
clinical course with non-neurological complications (n ¼ 6)
or persistent or improved neurological symptoms related to
spinal cord ischemia (n ¼ 7). During the TASP interval, no
major adverse embolic events involving the function of liver,
intestine, or the lower extremities were observed. However,
one patient presented 4 months after the primary bEVAR
with episodes of hemoptysis, suggesting an aortobronchial
ﬁstula (initial aneurysm diameter 5.6 cm) and died just
before the intended side branch completion. Unfortunately,
the patient was not readmitted to the hospital and no au-
topsy was performed. In 8 patients (22.8%) secondary side
branch completion was performed under local anesthesia.Aneurysm sac perfusion and patent intercostal and lumbar
arteries
During the TASP interval, visible perfusion of the aneurysm
sac was detected in 34/35 patients (97%), as evaluated by
CTA performed 3e5 days after bEVAR. The numbers of
intercostal and lumbar arteries before bEVAR were
19.0 4.2 in the non-TASP and 17.1 5.0 in the TASP group
and not related to severe SCI. Analysis of persistent type II
endoleaks visible on CTA after bEVAR and secondary side
branch completion showed no difference between the non-
TASP (5/43) and TASP group (6/40) and no correlation with
paraplegia. As a trend, more patent intercostal and lumbar
arteries within the TASP group were detected at the end of
the TASP interval when compared with the arteries visibleII thoracoabdominal aortic aneurysm treated with a four-branched
porary aneurysm sac perfusion (TASP) is shown by contrast in the
ostal artery (white arrow) at the level of Th2. (B) Completion of the
atent spinal cord perfusion.
Figure 3. Sixty-ﬁve-year-old man with a Crawford type II thoracoabdominal aneurysm (maximal diameter 6.2 cm) treated with a fourfold
branched endograft. (A, B) Temporary aneurysm sac perfusion via the non-completed side branch to the celiac trunk. Shown is the
perfusion of the aneurysm sac, even dorsally, and the contrast ﬂow in one lumbar artery (white arrows).
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10.9  4.6; p ¼ .08), probably supporting the TASP concept.Overall technical success and risk of rupture
Five of 40 patients (13%) did not receive secondary
completion of the TASP side branch. Two patients died after
the initial bEVAR implantation from cerebral infarction or
malignant disease. One patient denied side branch comple-
tion because of aneurysm regression, in one patient cannu-
lation of the right renal artery failed during two attempts
and, as mentioned before, one patient died during the TASP
interval. Two of these ﬁve patients required early revascu-
larization of the renal or superior mesenteric arteries. Overall
technical success, including aneurysm exclusion with bEVAR,
intended side branch TASP, absence of persistent and non-
intended type I or III endoleak, and secondary side branch
completion, was 35/40 patients (88%).
In 5/19 (26%) patients with a TASP interval >4 weeks a
relevant progression (5e16%) of their aneurysm diameter
was observed, all of them were asymptomatic. As already
mentioned, one patient died 4 months after bEVAR and
TASP from suspected aneurysm rupture. Therefore, the risk
of rupture during the TASP interval was 1/40 (3%) for all
TASP patients and 1/19 (5%) among the patients with
secondary side branch completion later than 4 weeks.Early endovascular reinterventions and organ dysfunction
Early side branch reinterventions were performed for 11/
306 (4%) branches in eight patients (10%) for high gradeFigure 4. (A) Intraoperative angiogram showing implantation of branche
superior mesenteric artery. (B) Temporary aneurysm sac perfusion via
lumbar arteries (black arrows). The patient has had left nephrectomystenosis and kinking (n ¼ 8, 3%) or type I or III endoleak
(n ¼ 3, 1%) with 3/43 (7%) and 5/40 (13%) patients in the
non-TASP and TASP group (Table 4). Reinterventions for
intended secondary side branch occlusion in the TASP group
are not included. Two patients (2%) initially received an
additional reno-visceral bypass to renal and hepatic arteries
by open surgery for renal and hepatic malperfusion; both
patients died. Three patients newly required dialysis (8%)
with renal side branches occluded perioperatively in addi-
tion to pre-existing occlusions of the contralateral renal
artery in two patients and progressive renal failure in one
patient.Perioperative mortality
Perioperative 30-day mortality was similar in both groups,
3/43 (7%) in the non-TASP group and 3/40 (8%; Table 4) in
the TASP group. Causes of death were intestinal ischemia
(n ¼ 3), multi-organ failure after multiple abdominal
embolic arterial occlusions (n ¼ 1), hemorrhage after intra-
arterial lysis for reno-visceral embolisation (n ¼ 1), and a
coagulation disorder with intracerebral hemorrhage in
another patient. Perioperative and short-term mortality in
TASP patients with inclusion of the reported mortality
during the TASP interval was 4/40 (10%).Neurologic complications
Severe SCI was observed in the non-TASP group immedi-
ately after the intervention in six patients and delayed in
one patient after 24e72 h. Within the TASP group, oned endograft with connecting stent grafts to the celiac trunk and the
the right renal artery with ﬂow to the aneurysm and at least four
for renal cancer.
Table 4. Perioperative results.
Non-TASP
(n ¼ 43)
TASP
(n ¼ 40)
General complication
Newly developed renal
failure/dialysis
2 (5) 1 (3)
Acute mesenteric ischemia 2 (5) 1 (3)
Perioperative mortality 3 (7) 3 (8)
Mortality during TASP interval d 1 (3)
Side branch complication
Early reinterventions 3 (7) 5 (13)
Note. Values are n (%). TASP ¼ temporary aneurysm sac perfusion.
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paraplegia immediately after bEVAR, while another devel-
oped paraplegia after the secondary side branch completion
after 2 months. These patients are included in the analysis
as severe SCI. In two patients with severe SCI, CSF drains
were reinserted to reduce spinal pressure and when not
initially accepted by the patient.
Intention-to-treat analysis of neurological adverse events
after the implantation of branched aortic stent grafts after
30 days or at discharge in the non-TASP or TASP group
included one versus two perioperative strokes, one versus
ﬁve paresthesias, one versus ﬁve temporary paraparesis,
and nine versus two patients with paraplegia (p ¼ .03).
Within the subgroup of Crawford type I-III aneurysms the
difference between the non-TASP and TASP group regarding
severe SCI was even more evident (7/24 vs. 1/29; p ¼ .01;
Table 5). Similar results were obtained when only those
TASP patients were analyzed, having received secondary
side branch completion (n ¼ 35, p ¼ 0.02 and n ¼ 26,
p > 0.01 in Crawford I-III patients), according to an as-
treated analysis.
DISCUSSION
This study evaluated the concept of TASP to maintain spinal
cord perfusion with the intention of reducing the risk of SCI
during bEVAR for TAAA. Based on the ﬁndings presented,
the described TASP concept is feasible and seems to reduce
the risk of severe SCI in patients with thoracoabdominal
bEVAR. At the end of the study period almost all patients
treated for TAAA received a staged TASP procedure. How-
ever, the risk of aneurysm rupture during the TASP interval
has to be considered and, based on our experience, early
side branch completion within 4 weeks is recommended
according to the presence or absence of symptoms of SCI.Table 5. Neurological complications.
Neurological complications Non-TASP (n ¼ 43) TASP (all
Acute cerebrovascular events 0 (0) 3 (1)
Paraesthesia 1 (2) 5 (13)
Temporary paraparesisb 1 (2) 5 (13)
paraplegia (day 30 or discharge)b 9 (21) 2 (5)
Subgroup of aneurysm type IeIII n ¼ 24 n ¼ 29
Paraplegia (d 30 or discharge)b 7 (29) 1 (3)
Note. Values are n (%) unless otherwise indicated. TASP ¼ temporary
a All in comparison to the non-TASP group.
b Muscle strength 0e2 according to the modiﬁed Tarlov scale.Overall post-interventional neurological complications
were observed in both groups, but patients in the TASP
group had less severe neurological deﬁcits and recovered
more rapidly within 30 days or by discharge. These ﬁndings
might support the concept of TASP with continued blood
ﬂow to intercostal and lumbar arteries to maintain residual
spinal cord perfusion.18,19 However, one patient had severe
SCI after secondary side branch completion after 2 months.
Therefore, it remains unclear if the TASP concept will pre-
vent late severe SCI weeks or months after secondary side
branch occlusion, probably in patients with insufﬁcient
expansion of the spinal cord collateral network. Therefore,
CSF drainage, normal hemoglobin levels and prevention of
hypotension are still the most crucial elements for periop-
erative management of patients treated for TAAA to reduce
the risk of SCI.21 Three patients in the TASP group had
supra-aortic embolic events. So far, our results do not
indicate an association between adverse cerebrovascular
embolic events and the usual left transaxillary access for
secondary TASP side branch completion. In addition, the
characteristics of the patients in the TASP group already
indicate a higher incidence of cerebrovascular events and
stroke in their past medical history.
Technical modiﬁcations of the branched stent grafts
might further improve the results obtained so far. How-
ever, all but one non-completed side branches, located on
the front side of the stent graft for the celiac trunk or
laterally for the renal arteries, remained open during the
TASP interval. It might be more physiological to position
these side branches proximal and distal to the reno-
visceral aortic segment, and at the dorsal side of the
stent graft, as previously reported.18 In addition, further
stent graft modiﬁcations might allow a staged and
controlled side branch ﬂow regulation either to reduce
side branch perfusion and intentionally occlude the TASP
side branch in patients without SCI, or to increase the side
branch and spinal perfusion with the option to reopen an
occluded perfusion branch in patients with immediate or
late symptoms of severe SCI. In addition, secondary TASP
side branch completion should preferentially be per-
formed by temporary side branch balloon occlusion in an
awake patient under local anesthesia and/or with neuro-
physiological monitoring to identify early neurological
deﬁcits related to SCI.16,19,23,24 Staged procedures with
secondary side branch occlusion would then be required
only in those patients with pathological motor evokedpatients) (n ¼ 40) pa TASP (completed) (n ¼ 35) pa
1 (3)
3 (9)
NS 5 (14) .04
.03 1 (3) .02
n ¼ 26
.01 0 (0) <.01
aneurysm sac perfusion; NS ¼ not signiﬁcant.
264 P.M. Kasprzak et al.responses during temporary balloon occlusion of the TASP
side branch.
Further attention needs to be addressed to the time
point for secondary completion of TASP side branches. It is
so far unknown if the length of the TASP interval is related
to the degree of expansion of the spinal cord collateral
network, associated with the intended prevention of severe
SCI. Furthermore, prolongation of the time interval until
secondary side branch completion is performed will in-
crease the risk of aneurysm progression and rupture, as
reported for one of the patients with an aneurysm diameter
<6 cm. Therefore, early secondary side branch completion
within 4 weeks should be recommended in patients without
a neurological deﬁcit. In patients with persistent SCI, or who
are just recovering from severe SCI, an individual recom-
mendation has to consider the risk of aneurysm rupture
after a TASP interval >4 weeks and the option for further
improvement of neurological symptoms. Intraoperative
balloon occlusion of the TASP side branch with additional
monitoring of motor-evoked potentials might allow the
identiﬁcation of patients being at increased risk of SCI or
those who will tolerate early side branch completion.25
In summary, this study, which investigated the concept of
TASP after bEVAR for TAAA, indicates that this approach
seems to be feasible, with promising results regarding a
reduced risk of severe SCI or paraplegia. Based on our
current knowledge, and considering the increased risk of
aneurysm rupture, secondary TASP side branch completion
should be performed early (after days or at least within 4
weeks) in patients without SCI with an option for an
extended TASP interval for patients with paraplegia or those
recovering from SCI. Intraoperative neurological monitoring
to identify early changes related to SCI, side branch
completion under local anesthesia and new stent graft
modiﬁcations regulating side branch aneurysm sac perfu-
sion might further improve this concept.
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